Cargando…
Mitogen-activated protein kinase phosphatase-1 (MKP-1) impairs the response to anti-epidermal growth factor receptor (EGFR) antibody cetuximab in metastatic colorectal cancer patients
BACKGROUND: The validation of KRAS mutations as a negative marker of response to anti-epidermal growth factor receptor (EGFR) antibodies has meant a seminal advance towards treatment individualisation of colorectal cancer (CRC) patients. However, as a KRAS wild-type status does not guarantee a respo...
Autores principales: | Montagut, C, Iglesias, M, Arumi, M, Bellosillo, B, Gallen, M, Martinez-Fernandez, A, Martinez-Aviles, L, Cañadas, I, Dalmases, A, Moragon, E, Lema, L, Serrano, S, Rovira, A, Rojo, F, Bellmunt, J, Albanell, J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2853100/ https://www.ncbi.nlm.nih.gov/pubmed/20234366 http://dx.doi.org/10.1038/sj.bjc.6605612 |
Ejemplares similares
-
FOXO3a and the MAPK p38 are activated by cetuximab to induce cell death and inhibit cell proliferation and their expression predicts cetuximab efficacy in colorectal cancer
por: Marzi, L, et al.
Publicado: (2016) -
Mitogen-activated protein kinase phosphatase-3 (MKP-3) in the surgical wound is necessary for the resolution of postoperative pain in mice
por: Skopelja-Gardner, Sladjana, et al.
Publicado: (2017) -
A role for mitogen-activated protein kinase phosphatase 1 (MKP1) in neural cell development and survival
por: Toulouse, André, et al.
Publicado: (2015) -
Dabrafenib in an elderly patient with metastatic melanoma and BRAF V600R mutation: a case report
por: Casadevall, David, et al.
Publicado: (2016) -
Mitogen-Activated Protein Kinase Phosphatase 3 (MKP-3)–Deficient Mice Are Resistant to Diet-Induced Obesity
por: Feng, Bin, et al.
Publicado: (2014)